Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
OFIX 
Orthofix Medical Inc (OFIX)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: OFIX (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -68.48% | Avg. Invested days 31 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 624.75M USD | Price to earnings Ratio - | 1Y Target Price 24.3 |
Price to earnings Ratio - | 1Y Target Price 24.3 | ||
Volume (30-day avg) 230831 | Beta 1.06 | 52 Weeks Range 12.08 - 20.73 | Updated Date 04/1/2025 |
52 Weeks Range 12.08 - 20.73 | Updated Date 04/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -3.3 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-03-03 | When Before Market | Estimate -0.05 | Actual 0.0154 |
Profitability
Profit Margin -15.76% | Operating Margin (TTM) -3.59% |
Management Effectiveness
Return on Assets (TTM) -4.5% | Return on Equity (TTM) -22.87% |
Valuation
Trailing PE - | Forward PE 20.04 | Enterprise Value 721140096 | Price to Sales(TTM) 0.78 |
Enterprise Value 721140096 | Price to Sales(TTM) 0.78 | ||
Enterprise Value to Revenue 0.9 | Enterprise Value to EBITDA 34.53 | Shares Outstanding 39022500 | Shares Floating 37884596 |
Shares Outstanding 39022500 | Shares Floating 37884596 | ||
Percent Insiders 5.34 | Percent Institutions 86.31 |
Analyst Ratings
Rating 4 | Target Price 24.4 | Buy 1 | Strong Buy 2 |
Buy 1 | Strong Buy 2 | ||
Hold 2 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Orthofix Medical Inc
Company Overview
History and Background
Orthofix Medical Inc. was founded in 1980. Initially focused on external fixation devices, it has expanded through acquisitions and organic growth to offer a broad portfolio of orthopedic and spine solutions. The company has evolved into a global player in the medical device industry.
Core Business Areas
- Spine: Focuses on developing and marketing spinal implants, biologics, and bone growth therapies to address spinal disorders.
- Orthopedics: Provides external fixation, bone growth stimulation, and other orthopedic solutions for fracture care and limb reconstruction.
- Biologics: Development and marketing of regenerative products to aid in the healing of bone and soft tissue.
Leadership and Structure
The leadership team consists of the CEO, CFO, and various VPs heading different business units and functions. The organizational structure is functional, with departments for R&D, sales, marketing, operations, and finance.
Top Products and Market Share
Key Offerings
- Spinal Implants: Offers a range of spinal implants for fusion and motion preservation. Market share data unavailable. Competitors include Medtronic (MDT), Johnson & Johnson (JNJ), and NuVasive (NUVA).
- Bone Growth Stimulators: Non-invasive devices that promote bone healing. Market share data unavailable. Competitors include Zimmer Biomet (ZBH) and DJO Global.
- External Fixation Systems: Used for fracture stabilization and limb lengthening. Market share data unavailable. Competitors include Smith & Nephew (SNN) and Stryker (SYK).
Market Dynamics
Industry Overview
The medical device industry is characterized by innovation, regulatory scrutiny, and increasing demand due to an aging population and advancements in healthcare. The market is competitive and fragmented.
Positioning
Orthofix is a mid-sized player in the orthopedic and spine market, with a focus on specialized solutions and innovation. It aims to compete through product differentiation and expanding its global presence.
Total Addressable Market (TAM)
The global orthopedic device market is expected to reach hundreds of billions of dollars. Orthofix is positioned to capture a portion of this market through its diverse product portfolio and strategic acquisitions.
Upturn SWOT Analysis
Strengths
- Diverse product portfolio
- Established brand reputation
- Global distribution network
- Strong R&D capabilities
Weaknesses
- Smaller market share compared to major competitors
- Dependence on product innovation
- Exposure to regulatory risks
- Financial leverage
Opportunities
- Expanding into emerging markets
- Acquiring complementary businesses
- Developing innovative products
- Partnerships with healthcare providers
Threats
- Intense competition
- Pricing pressures
- Regulatory changes
- Economic downturns
Competitors and Market Share
Key Competitors
- MDT
- JNJ
- ZBH
- SYK
- SNN
- NUVA
Competitive Landscape
Orthofix faces intense competition from larger players with greater resources. Orthofix competes on product innovation, customer service, and niche market focus.
Major Acquisitions
SeaSpine Holdings Corporation
- Year: 2023
- Acquisition Price (USD millions): 330
- Strategic Rationale: Expand portfolio into Orthopedics and spine
Growth Trajectory and Initiatives
Historical Growth: Growth trends can be assessed based on past financial reports and strategic initiatives.
Future Projections: Future growth projections are based on market trends, product pipeline, and analyst estimates. Information not available.
Recent Initiatives: Recent initiatives may include product launches, acquisitions, and strategic partnerships.
Summary
Orthofix is a mid-sized medical device company with a diversified product portfolio and a global presence. Its strengths lie in its innovative solutions and established brand. However, it faces challenges from larger competitors and needs to effectively execute its growth strategies and address regulatory risks.
Similar Companies
BSX
Boston Scientific Corp
BSX
Boston Scientific Corp
JNJ
Johnson & Johnson
JNJ
Johnson & Johnson
MDT
Medtronic PLC
MDT
Medtronic PLC
SNN
Smith & Nephew SNATS Inc
SNN
Smith & Nephew SNATS Inc
SYK
Stryker Corporation
SYK
Stryker Corporation
ZBH
Zimmer Biomet Holdings Inc
ZBH
Zimmer Biomet Holdings Inc
Sources and Disclaimers
Data Sources:
- Company website
- SEC filings
- Industry reports
- Analyst estimates
Disclaimers:
This analysis is based on publicly available information and is not financial advice. The information provided is for informational purposes only and should not be considered a recommendation to buy or sell any stock.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Orthofix Medical Inc
Exchange NASDAQ | Headquaters Lewisville, TX, United States | ||
IPO Launch date 1992-04-24 | President, CEO, Director and Interim President of Global Spine Mr. Massimo Calafiore | ||
Sector Healthcare | Industry Medical Devices | Full time employees 1616 | Website https://orthofix.com |
Full time employees 1616 | Website https://orthofix.com | ||
Orthofix Medical Inc. operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulation devices that enhance bone fusion, including adjunctive and noninvasive treatment of the cervical and lumbar spine, as well as a therapeutic treatment for non-spinal, appendicular fractures, and fresh fractures that have not healed; designs, develops, and markets a portfolio of spine fixation and motion preservation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and provides 7D flash navigation system for spine and cranial procedures. Its Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.